THE IMPACT OF NON-VITAMIN K ANTAGONIST ORAL ANTICOAGULANTS USE IN TRAUMA PATIENTS

  • Tautvydas Vaitkus Lietuvos sveikatos mokslų universitetas
  • Rūta Marija Nadišauskaitė Lietuvos sveikatos mokslų universitetas
  • Edita Mašanauskienė LSMU Kauno ligoninė
Keywords: trauma, hematoma, anticoagulant therapy, non vitamin K antagonist, rivaroxaban

Abstract

The aging population and growing numbers of patients with cardiovascular diseases worldwide has caused an increasing demand for anticoagulation therapy. Direct non vitamin K antagonist have been licensed for a long-term prevention and treatment of thromboembolism. However, the clinical evidence for its impact in trauma cases is lacking. In this case report, we present a 76-year-old female trauma patient who had been using non vitamin K antagonist prior the trauma. Due to use of non vitamin K antagonist and other drugs, the patient developed a massive, subcutaneous hematoma in her buttocks. In this case report, we discuss the impact of non vitamin K antagonist in trauma patients; the development of complications as well as the treatment.

Published
2021-02-18